SEC ownership of Tectonic Therapeutic, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001681087.

Comparable stake leader

Timothy A. Springer

Disclosed value leader

Timothy A. Springer

Comparable rows

50/50

Latest evidence

30 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Timothy A. Springer
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001681087
Issuer location
Watertown, MA

Ownership snapshot

Top shareholders of Tectonic Therapeutic, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Timothy A. Springer
Disclosed value leader
Timothy A. Springer
Comparable rows
50/50
Latest evidence
30 Jun 2026
3/4/5 13D/G 13F Lead comparable stake: 32% 13D/G row: Timothy A. Springer Showing 1-8 of 50 holder rows.

Quick read

Timothy A. Springer leads the comparable SEC ownership view at 32%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Timothy A. Springer's linked filing trail.
Comparable ownership Top 5
Timothy A. Springer 32%
FMR LLC 15%
Terrance McGuire 6.3%
TCG Crossover GP II, LLC 6.2%
Aberdeen Group plc 6.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Timothy A. Springer
3/4/5 13D/G
Director, 10%+ Owner
32%
from 13D/G
$98,256,953
6,034,538 shares
mixed-class rows
09 Jun 2026
FMR LLC
13F 13D/G
Company
15%
from 13D/G
$97,294,233
2,830,378 shares
30 Jun 2026
Terrance McGuire
13D/G 3/4/5
Director
6.3%
$14,725,503
657,976 shares
-$11,190,022 03 Apr 2025
TCG Crossover GP II, LLC
13D/G
Chen Yu
6.2%
$24,202,334
1,169,760 shares
$0 12 Feb 2026
Aberdeen Group plc
13F 13D/G
Company
6.1%
from 13D/G
$39,250,200
1,141,824 shares
30 Jun 2026
TCG Crossover Management, LLC
13F
Company
13F
6.4%
$41,418,128
1,204,891 shares
30 Jun 2026
BlackRock, Inc.
13F
Company
13F
4.6%
$29,651,600
862,592 shares
30 Jun 2026
First Light Asset Management, LLC
13F
Company
13F
4.2%
$27,524,958
800,726 shares
30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$454,677.

Buys
$182,410
Insiders: 2
Sells
$637,087
Insiders: 2
Net
-$454,677
Shares: -13,341
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 8,500 Shares: 21,841
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 215 $0 $7,525 -$7,525
3-6 0 21,626 $0 $629,562 -$629,562
6-9 8,500 0 $182,410 $0 +$182,410
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 28 reporting-owner rows connected to Tectonic Therapeutic, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
28
Largest Forms 3/4/5 holder
Timothy A. Springer
Net 12M change
-$454,677
Latest report
12 Aug 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Timothy A. Springer Director, 10%+ Owner $98,256,953 Mixed 09 Jun 2026
Alise Reicin Chief Executive Officer, Director $13,527,853 +$52,750 +0.39% Mixed 20 Jun 2026
Terrance McGuire Director $9,799,360 Filing P/S 09 Jun 2025
Marcella K. Ruddy Chief Medical Officer $2,030,460 -$363,000 -15% Filing P/S 04 May 2026
Peter McNamara Chief Scientific Officer $1,934,975 -$274,087 -12% Filing P/S 12 Aug 2026
Daniel Lochner Chief Financial Officer $1,329,534 +$129,660 +11% Mixed 11 Jun 2026
Marc Schwabish Chief Business Officer $1,029,080 Mixed 04 Mar 2026
Braden M. Leonard Former 10% owner of AVROBIO $563,795 Mixed 20 Jun 2024
Geoffrey Mackay President & CEO, Director $360,981 Mixed 08 Feb 2023
Azadeh Golipour Chief Technology Officer $201,602 Mixed 01 Feb 2024
Erik Ostrowski Interim CEO, President and CFO $179,740 Mixed 01 Feb 2024
Christian Cortis Chief Operating Officer $164,278 Mixed 20 Jun 2024
Steven N. Avruch Chief Legal Officer $145,161 Mixed 01 Feb 2024
Essra Ridha Chief Medical Officer $137,463 Mixed 01 Feb 2024
Deanna M. Petersen Chief Business Officer $104,052 Mixed 08 Feb 2023
Stefan Vitorovic Director $36,106 Mixed 09 Jun 2026
Praveen P. Tipirneni Director $3,948 Mixed 09 Jun 2026
Annalisa Jenkins Director Mixed 06 Jun 2023
Philip J. Vickers Director Mixed 06 Jun 2023
Bruce Booth Director Mixed 06 Jun 2023

Recent insider transactions for Tectonic Therapeutic, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Peter McNamara TECX Common Stock Sale -0.08% $1,505 $35.00 -43 55,285 12 Aug 2026 Direct
Peter McNamara TECX Common Stock Options Exercise 0.08% 43 55,328 12 Aug 2026 Direct
Peter McNamara TECX Employee Stock Option (Right to Buy) Options Exercise -0.55% -43 7,830 12 Aug 2026 Direct
Peter McNamara TECX Common Stock Sale -0.31% $6,020 $35.00 -172 55,285 30 Jun 2026 Direct
Peter McNamara TECX Common Stock Options Exercise 0.31% 172 55,457 30 Jun 2026 Direct
Peter McNamara TECX Employee Stock Option (Right to Buy) Options Exercise -2.14% -172 7,873 30 Jun 2026 Direct
Alise Reicin TECX Common Stock Tax liability -0.3% -924 310,623 20 Jun 2026 Direct
Daniel Lochner TECX Performance Stock Option (Right to Buy) Award 7,500 7,500 11 Jun 2026 Direct
Timothy A. Springer TECX Stock Option (Right to Buy) Award 10,200 10,200 09 Jun 2026 Direct
Praveen P. Tipirneni TECX Stock Option (Right to Buy) Award 10,200 10,200 09 Jun 2026 Direct
Phillip B. Donenberg TECX Stock Option (Right to Buy) Award 10,200 10,200 09 Jun 2026 Direct
Stefan Vitorovic TECX Stock Option (Right to Buy) Award 10,200 10,200 09 Jun 2026 Direct
Jessica Caroline Chutter TECX Stock Option (Right to Buy) Award 20,400 20,400 08 Jun 2026 Direct
Marcella K. Ruddy TECX Common Stock Sale -1.55% $31,950 $30.00 -1,065 67,682 04 May 2026 Direct
Marcella K. Ruddy TECX Common Stock Sale -1.43% $31,050 $31.05 -1,000 68,747 01 Apr 2026 Direct
Francois Nader TECX Stock Option (Right to Buy) Award 20,400 20,400 01 Apr 2026 Direct
Marcella K. Ruddy TECX Common Stock Sale -12.5% $300,000 $30.00 -10,000 69,747 06 Mar 2026 Direct
Peter McNamara TECX Common Stock Sale -10.2% $188,935 $30.17 -6,262 55,285 06 Mar 2026 Direct
Peter McNamara TECX Common Stock Options Exercise 4.61% 2,715 61,547 06 Mar 2026 Direct
Peter McNamara TECX Employee Stock Option (Right to Buy) Options Exercise -25.2% -2,715 8,045 06 Mar 2026 Direct
Alise Reicin TECX Common Stock Award 32.6% 76,500 311,547 04 Mar 2026 Direct
Alise Reicin TECX Employee Stock Option (Right to Buy) Award 69,250 69,250 04 Mar 2026 Direct
Marc Schwabish TECX Common Stock Award 75.5% 19,500 45,314 04 Mar 2026 Direct
Marc Schwabish TECX Employee Stock Option (Right to Buy) Award 17,750 17,750 04 Mar 2026 Direct
Peter McNamara TECX Common Stock Sale -2.73% $41,250 $25.00 -1,650 58,832 04 Mar 2026 Direct
Peter McNamara TECX Common Stock Award 61.4% 23,000 60,482 04 Mar 2026 Direct
Peter McNamara TECX Employee Stock Option (Right to Buy) Award 21,000 21,000 04 Mar 2026 Direct
Daniel Lochner TECX Common Stock Award 82.7% 26,500 58,544 04 Mar 2026 Direct
Daniel Lochner TECX Employee Stock Option (Right to Buy) Award 24,250 24,250 04 Mar 2026 Direct
Marcella K. Ruddy TECX Common Stock Award 49.8% 26,500 79,747 04 Mar 2026 Direct
Marcella K. Ruddy TECX Employee Stock Option (Right to Buy) Award 24,250 24,250 04 Mar 2026 Direct
Peter McNamara TECX Common Stock Sale -4.21% $36,377 $22.06 -1,649 37,482 03 Mar 2026 Direct
Alise Reicin TECX Common Stock Purchase 2.01% $52,750 $21.10 2,500 127,030 11 Feb 2026 By Trust
Marc Schwabish TECX Common Stock Options Exercise 21.1% 4,500 25,814 10 Feb 2026 Direct
Marc Schwabish TECX Employee Stock Option (Right to Buy) Options Exercise -5.2% -4,500 82,014 10 Feb 2026 Direct
Daniel Lochner TECX Common Stock Purchase 23% $129,660 $21.61 6,000 32,044 10 Feb 2026 Direct
Marc Schwabish TECX Common Stock Tax liability -7.06% -1,619 21,314 04 Feb 2026 Direct
Marcella K. Ruddy TECX Common Stock Tax liability -3.73% -2,064 53,247 04 Feb 2026 Direct
Alise Reicin TECX Common Stock Tax liability -1.72% -4,104 235,047 04 Feb 2026 Direct
Peter McNamara TECX Common Stock Tax liability -4.28% -1,748 39,131 04 Feb 2026 Direct
Daniel Lochner TECX Common Stock Tax liability -7.39% -2,077 26,044 04 Feb 2026 Direct
Alise Reicin TECX Common Stock Options Exercise 4.81% 10,966 239,151 31 Dec 2025 Direct
Alise Reicin TECX Employee Stock Option (Right to Buy) Options Exercise -32.3% -10,966 22,957 31 Dec 2025 Direct
Peter McNamara TECX Common Stock Options Exercise 20.7% 7,000 40,879 22 Dec 2025 Direct
Peter McNamara TECX Employee Stock Option (Right to Buy) Options Exercise -21.8% -7,000 25,065 22 Dec 2025 Direct
Marc Schwabish TECX Common Stock Award 22.5% 4,210 22,933 25 Sep 2025 Direct
Marc Schwabish TECX Employee Stock Option (Right to Buy) Award 7,650 7,650 25 Sep 2025 Direct
Peter McNamara TECX Common Stock Award 15.5% 4,550 33,879 25 Sep 2025 Direct
Peter McNamara TECX Employee Stock Option (Right to Buy) Award 8,260 8,260 25 Sep 2025 Direct
Daniel Lochner TECX Common Stock Award 23.9% 5,430 28,121 25 Sep 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .